Use of the 4-Hydroxy-Triazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor Ligands

We report a series of glutamate and aspartate analogues designed using the hydroxy-1,2,3-triazole moiety as a bioisostere for the distal carboxylic acid. Compound 6b showed unprecedented selectivity among AMPA receptor subtypes, confirmed also by an unusual binding mode observed on the crystal struc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2019-04, Vol.62 (9), p.4467-4482
Hauptverfasser: Sainas, Stefano, Temperini, Piero, Farnsworth, Jill C., Yi, Feng, Møllerud, Stine, Jensen, Anders A., Nielsen, Birgitte, Passoni, Alice, Kastrup, Jette S., Hansen, Kasper B., Boschi, Donatella, Pickering, Darryl S., Clausen, Rasmus P., Lolli, Marco L.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We report a series of glutamate and aspartate analogues designed using the hydroxy-1,2,3-triazole moiety as a bioisostere for the distal carboxylic acid. Compound 6b showed unprecedented selectivity among AMPA receptor subtypes, confirmed also by an unusual binding mode observed on the crystal structures in complex with the AMPA receptor GluA2 agonist binding domain. Here, a methionine (Met729) was highly disordered compared to previous agonist-bound structures. This observation provides a possible explanation for the pharmacological profile. In the structure with 7a , an unusual organization of water molecules around the bioisostere arises compared to previous structures of ligands with other bioisosteres. Aspartate analogue 8 with the hydroxy-1,2,3-triazole moiety directly attached to glycine was unexpectedly able to activate both the glutamate and glycine agonist binding sites of the NMDA receptor. These observations demonstrate novel features that arise when employing a hydroxyl-triazole moiety as bioisostere for the distal carboxylic acid in glutamate receptor agonists.
ISSN:0022-2623
1520-4804
DOI:10.1021/acs.jmedchem.8b01986